Fish is a good source of nutrients for humans but can pose a risk to human health because of the possible presence of some xenobiotics such as heavy metals and persistent organic contaminants. Constant monitoring is needed to minimize health risks and ensure product quality and consumer safety. The aim of the present study was to use atomic absorption spectrometry to determine the concentrations of some heavy metals (Hg, Pb, and Cd) in tuna packaged in different kinds of packages (cans or glass) in various countries (Italy and elsewhere). Concentrations of Cd and Hg were within the limits set by European Commission Regulation (EC) No 1881/2006 and in many samples were below the detection limit. Pb concentrations exceeded European limits in 9.8% of the analyzed samples. These results are reassuring in terms of food safety but highlighted the need to constantly monitor the concentrations of heavy metals in fish products that could endanger consumer health.
Aflatoxin B1 (AFB1) is a mycotoxin produced by Aspergillus spp. that can occur as a natural contaminant in foods and feeds of vegetable origin. Post-ingestion, AFB1 can be metabolized in the liver of mammals into hydroxylated aflatoxin M1 (AFM1) that is excreted with milk. Although several studies have been carried out to evaluate effects of AFB1 on the immune system, studies regarding AFM1 are moreover lacking. The aim of the current study was to investigate effects of AFB1 and AFM1 on immune function using a lymphoblastoid Jurkat T-cell line as an experimental model. Both AFB1 and AFM1 produced significant decreases in Jurkat cell proliferation, whereas only minor effects were noted on interleukin (IL)-2 and interferon (IFN)-γ cytokines mRNA expression in stimulated cells that had been pre-incubated with AFB1 and AFM1. Particularly, AFB1, but not AFM1, at the highest concentration (50 µM) induced a marked increase in IL-8 mRNA expression. The results of the current study suggested the existence of a concentration threshold for AFB1 and AFM1 needed to exert biological activity on cell viability and innate immunity.
Herbal drugs are more and more used both in human and veterinary medicine to mitigate and prevent minor diseases and to support conventional medicine using allopathic drugs. Nevertheless, ‘natural product’ does not mean lack of adverse effects, and many people and veterinarians do not know enough about the adverse reactions that can occur following the administration of such drugs in domestic animals. Moreover, herbal products can interact with each other when administered concomitantly or can agonize or antagonize the effects of synthetic drugs administered as primary therapy. The use of non-conventional medicines (NCM) should be considered as a veterinary practise. In this paper, the herbal drugs most utilized in domestic animals, both pets and large animals, are reviewed, as their use is increasing, despite the prejudices of the academic world and some of the adverse effects and interactions that can occur in domestic animals.